Podcasts about psychedelic research

Psychedelic therapy is on the verge of reshaping mental health, trauma healing, and human consciousness. This episode reveals what's really happening behind the scenes at the FDA, inside pharmaceutical companies, and within the global movement to legalize MDMA-assisted therapy. Watch this episode on YouTube for the full video experience: https://www.youtube.com/@DaveAspreyBPR Host Dave Asprey sits down with Rick Doblin, PhD, the legendary founder of MAPS and one of the most influential figures in psychedelic science. With nearly 40 years leading clinical research on MDMA, psilocybin, and trauma healing, Rick brings unmatched insight into how these compounds are transforming functional medicine, emotional resilience, and neuroplasticity. They break down the regulatory battle over MDMA therapy, the clash between pharmaceutical profit and public benefit, and the urgent need to combine pharmacology with therapy for real results. You'll also learn how psychedelics impact neurohacking, epigenetics, and the default mode network—and why the next frontier of self-transformation may be couples therapy with MDMA. This episode offers critical knowledge for anyone serious about biohacking, trauma release, mental performance, and accessing deeper states of healing. This podcast channel dives into the intersections of psychedelics with fasting, ketosis, cold therapy, and self-quantification—and how altered states can unlock more energy, better relationships, and lasting change. You'll Learn: • Why separating therapy from psychedelics is the most dangerous path forward • How MAPS evolved into a public benefit pharma company—and what went wrong • The real story behind the FDA's rejection of MDMA therapy in 2024 • How MDMA affects neuroplasticity, mitochondria, and trauma recovery • Why group therapy and couples therapy are the future of psychedelic healing • The dangers of overusing ketamine—and how it's being exploited by profit-driven clinics • What the Psychedelic Science 2025 conference will reveal about the future of medicine, spirituality, and consciousness hacking • How psychedelics could reverse epigenetic trauma passed down through generations • The role of default mode network suppression in spiritual experiences and trauma resolution • Why the war on drugs was never about safety—and what a post-drug-war world might look like Dave Asprey is a four-time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade is the top podcast for people who want to take control of their biology, extend their longevity, and optimize every system in the body and mind. Each episode features cutting-edge insights in health, performance, neuroscience, supplements, nutrition, neurohacking, emotional intelligence, and conscious living. Episodes are released every Tuesday and Thursday, where Dave asks the questions no one else dares, and brings you real tools to become more resilient, aware, and high performing. SPONSORS: - Leela Quantum Tech | Head to https://leelaq.com/DAVE for 10% off- ARMRA | Go to https://tryarmra.com/ and use the code DAVE to get 15% off your first order Resources: • Dave Asprey's New Book - Heavily Meditated: https://daveasprey.com/heavily-meditated/ • Psychedelic Science Conference 2025 Website – https://www.psychedelicscience.org/ • Rick's Website: https://maps.org/ • Danger Coffee: https://dangercoffee.com • Dave Asprey's Website: https://daveasprey.com • Dave Asprey's Linktree: https://linktr.ee/daveasprey • Upgrade Collective – Join The Human Upgrade Podcast Live: https://www.ourupgradecollective.com • Own an Upgrade Labs: https://ownanupgradelabs.com • Upgrade Labs: https://upgradelabs.com • 40 Years of Zen – Neurofeedback Training for Advanced Cognitive Enhancement: https://40yearsofzen.com Timestamps: • 00:00 Trailer • 02:00 Intro • 03:43 Rise of Psychedelic Pharma • 05:00 Therapy vs. Profit • 06:44 Neurofeedback + Psychedelics • 08:28 Origins of Drug Laws • 14:06 MDMA Safety + Usage • 16:32 Psychedelics in Therapy + Meditation • 25:18 Psychedelic Hierarchy for New Users • 26:51 Psychedelic Churches + Culture • 28:58 Ayahuasca: Spiritual Insights • 30:24 MDMA and Federal Policy • 31:09 Inside the FDA Decision • 32:52 Therapeutic Promise of Psychedelics • 34:43 Psychedelics + Spirituality • 37:37 Neuroscience of Psychedelics • 40:12 Epigenetics + Generational Trauma • 43:50 War on Drugs Revisited • 46:37 Future of Legalization • 49:55 MDMA for Couples • 51:29 Group Therapy with Psychedelics • 52:26 Psychedelic Science 2025 Preview See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Robin Carhart-Harris, PhD joins to elucidate the intersection of psychedelics and neuroplasticity. Dr. Carhart-Harris is the Ralph Metzner Distinguished Professor in Neurology and Psychiatry at the University of California, San Francisco. Robin founded the Centre for Psychedelic Research at Imperial College London in April 2019, was ranked among the top 31 medical scientists in 2020, and in 2021, was named in TIME magazine's ‘100 Next' – a list of 100 rising stars shaping the future. Dr. Carhart-Harris begins by discussing the impact of psychedelics on neuroplasticity and mental health. He explains neuroplasticity as the brain's ability to change, emphasizing its role in mood disorders and substance use and describes how stress atrophies the brain, leading to mental illness. Dr. Carhart-Harris differentiates between neuroplasticity and neurogenesis, noting that while neurogenesis is limited in adults, neuroplasticity can be influenced by psychedelics like ketamine, psilocybin, and MDMA. In closing, he also discusses the entropic brain hypothesis, suggesting that increased brain entropy leads to richer subjective experiences.    In this episode, you'll hear: The relationship between neuroplasticity and “canalization”  Why homeostatic neuroplasticity may promote mental wellbeing Differences between ketamine, MDMA, and serotonergic psychedelics in terms of neuroplasticity The details of the entropic brain hypothesis Psychedelics' effect on the default mode network The frontiers of research into psychedelics and neuroplasticity  Quotes: “So changeability is what plasticity is. And neuroplasticity—that's the ability of the brain to change. Okay, and how is neuroplasticity related to mood disorders like depression and anxiety or substance use disorder or something like that? Well, that's a great question cause we don't have it entirely nailed down. But one of the most reliable findings in biological psychiatry is that stress atrophies the brain.” [2:47] “The main thing with ketamine is that the window of increased plasticity is brief… That makes sense because that reflects how ketamine seems to work therapeutically—that it provides relief somewhat short-term, unless it is twinned with, say, psychotherapy or you do repeat administration and get someone out of the rut they were in.” [22:15] “We've seen in people with depression, brain networks can become quite segregated from each other—they are ordinarily, they're quite functionally separate and distinct—but that modularity might be a bit elevated in depression. But what we've seen with psilocybin therapy is that separateness between systems, that segregated quality of organization of brain networks, brain systems actually decreases after psilocybin therapy for depression. I'll put it another way: the brain looks more globally interconnected after psilocybin therapy for depression and the magnitude of that… correlates with improvements.” [39:19]   Links: Carhart-Harris Lab website Dr. Carhart-Harris on X Dr. Carhart-Harris' 2025 article: “Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models” Dr. Carhart-Harris' 2012 article: “Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin” Dr. Carhart-Harris' 2010 article with Karl Friston: “The default-mode, ego-functions and free-energy: a neurobiological account of Freudian ideas” Psychedelic Medicine Association Porangui

What if the path to healing trauma isn't just through talk therapy, but through carefully guided psychedelic experiences? In this episode of The Practice of Therapy Podcast, I sit down with Dori, an experienced therapist and psychedelic facilitator, who shares her deeply informed perspective on the nuanced, responsible, and transformational use of medicines like ketamine, MDMA, and psilocybin mushrooms. Dori doesn't just follow trends—she's been on the frontlines, participating in research, working underground before legalization, and now helping clients access inner healing intelligence in a grounded, therapeutic way. If you're curious about how psychedelics actually fit into trauma work, when they're appropriate, and why they're not a one-size-fits-all miracle, this conversation will challenge your thinking and expand your clinical toolkit. Tune in to discover how seasoned therapists like Dori are bridging science, soul, and therapy to help clients heal in ways traditional methods sometimes can't reach. Are you ready to explore the real story behind the hype? Let's dive in. Resources Mentioned In This Episode  Use the promo code “GORDON” to get 2 months of Therapy Notes free Google Ads for Therapists Consulting with Gordon Mental Health Wear TN Watch this episode on YouTube Read the show notes here Meet Dori Lewis Dori Lewis, MA, MEd, LPC-S, is a co-founder of Elemental Psychedelics and the owner-operator of Reflective Healing in Fort Collins, CO—a psychotherapy group practice that specializes in psychedelic therapy using ketamine, integration therapy, transpersonal psychotherapy, and clinical supervision. With over a decade of clinical experience, Dori blends transpersonal psychology, depth work, and psychedelic-assisted therapy within a model that centers the therapeutic relationship. To date, she has stewarded nearly 100 ketamine therapy sessions and countless more individual and group ceremonies. She has also been trained and mentored in shamanic ritual, which has helped her bridge traditional counseling practice with transpersonal and existential realms—spaces that can hold incredible meaning and connection for clients. As an educator and trainer, Dori has delivered numerous talks to the professional psychedelic community through the Nowak Society and other guest lectures. In 2022, she spoke on the importance of psychedelic facilitator ethics through the lens of existential shadow work as a main stage speaker at the Emergence Festival. She co-teaches introductory psychedelic therapy workshops and served as a core lead faculty member with the Psychedelic Research and Training Institute (PRATI) from 2020 to 2023, where she specialized in training new and experienced clinicians on topics like set and setting, ethical ceremony, cultural appropriation in spiritual practices, and ritual in ketamine-assisted psychotherapy. As interest in psychedelic medicine grows, Dori believes it is the responsibility of those with a voice in professional and psychedelic communities to stay informed—and to intercept and challenge disinformation and questionable ethical practices emerging in the public arena. Website

We are excited to host Tommaso Barba for this episode on the Mangu.tv podcast series. Tommaso Barba is a PhD candidate at the Centre for Psychedelic Research, Imperial College London, exploring the brain effects of short-acting psychedelics such as DMT and 5-MeO-DMT. Under the supervision of Dr. David Erritzoe, Prof. David Nutt and Dr. Chris Timmermann, his work focuses on the potential to treat depression and enhance well-being. He authored the first scientific paper on psychedelics on sexual functioning, published in Nature Scientific Reports and compared psilocybin to antidepressants. With a background in neuroscience and psychoanalysis from Maastricht University, Tommaso also investigates psychedelics' impact on romantic intimacy. A passionate science communicator, he engages audiences via LinkedIn and X.Tommaso shares the story of his upbringing in Bologna, Italy.  He speaks about his fascination with psychoanalysis from a young age, his early confusion with sexuality, and rise in popularity due to his social media presence. He speaks about his disenchantment with the world he was in, and the superficiality of some of his relationships, as well as the cathartic moment, and subsequent fascination in mind and altered states. Giancarlo and Tommaso discuss expanded states and the mind's capacity to go beyond the subconscious. They speak about holotropic breathwork, the internal family system, and the varying acceptance of wisdom and madness depending on perspective and place. Tommaso shares upcoming and current projects, and speaks about his various trials with psychedelics, relationships and the mind, at Imperial College London.

Olga Chernoloz is not your average neuroscientist and clinical pharmacologist; she has a creative, playful, and curious side to her that enhances both her personal and professional life. In this episode, we explore the intersection of psychedelic research, creativity, and the regulatory state of psychedelics in 2025. We tease her very fun book, Psychedelics A to Z, which provides an in-depth, illustrated guide through the world of psychedelics, from the science behind them to their therapeutic potential, and everything in between. Olga also discusses her efforts to bring legal psychedelic medicine to Ukraine through her nonprofit, Phoenix Ukraine. This episode is packed with valuable insights into the scientific, personal, and creative facets of psychedelic work, as well as how these substances have the potential to revolutionize mental health treatment.Explore Coaching with Lana:⁠⁠Iboga Integration & Prep Coaching⁠⁠⁠⁠⁠ (NEW-now enrolling)⁠⁠Psychedelically Informed Life Coaching⁠⁠⁠⁠⁠ (6 Month ProgramKey Topics Covered:Olga's Journey: How she transitioned from traditional neuroscience and pharmacology to psychedelic research.Psychedelics A to Z: A look into the creative process behind Olga's accessible book.Psychedelics in Mental Health: The current landscape of psychedelic medicine and its potential to treat mental health conditions.Creativity and Psychedelics: How psychedelics foster creative thinking, problem-solving, and neuroplasticity.Phoenix Ukraine: Efforts to bring legal psychedelic medicine to Ukraine and the nuances of on trauma healing.Ethics and Research: Navigating the ethical challenges and cultural considerations in the world of psychedelic medicine.Play as a Tool: Exploring the role of play, nature, and creativity.Psychedelic Research Challenges: The importance of consistent research and quality studies to support the therapeutic use of psychedelics.Future of Psychedelics: The exciting prospects of psychedelics in therapy, particularly in the EU.Resources Mentioned:⁠Psychedelics A to Z:⁠ An Illustrated Journey Through the Captivating World of Psychedelics [Olga's book]⁠Phoenix Ukraine⁠ Olga's nonprofit initiative working to bring legal psychedelic medicine to Ukraine.Stay Connected to Modern Psychedelics:Instagram: ⁠⁠⁠⁠@modernpsychedelics⁠⁠⁠⁠YouTube: ⁠⁠⁠⁠Modern Psychedelics YouTube⁠⁠⁠⁠Website: ⁠⁠⁠⁠www.modernpsychedelics.net⁠⁠⁠⁠Substack: ⁠The Healthy Ego⁠⁠⁠Free Resources:⁠FREE Iboga Preparation Guide⁠⁠⁠FREE Set Better Goals⁠⁠⁠FREE Integration Journal⁠⁠FREE Intention Setting Journal⁠⁠⁠FREE Psychedelic Ceremony Checklist⁠⁠⁠FREE Playlists for Psychedelic Journeys + Integration⁠⁠DISCLAIMER: Modern Psychedelics does not endorse or support the illegal consumption of any substances. This show is meant for entertainment purposes only. Modern Psychedelics does not sell or promote the sale of any illegal substances. The thoughts, views, and opinions on this show should not be taken as life advice, medicinal advice, or therapeutic guidance.

In this episode of the Flex Diet Podcast, I sit down with Dr. James Fadiman and Jordan Gruber to talk all things microdosing—what it is, what it isn't, and why it's gaining so much traction in health, performance and even mental clarity.We dig into their new book, Microdosing for Healing, Health, and Enhanced Performance, and cover everything from the history of psychedelics to the latest research and how people are using tiny doses of these compounds to potentially improve cognitive function, mood and physical performance.We also talk about personal experience—what they've seen, what they've felt, and what they've learned along the way. Of course, none of this is medical advice. These substances still live in legal gray zones depending on where you are, so proceed with caution and do your homework.If you're curious about the science and the real-world implications of microdosing, this episode is a must-listen. Let's get into it.Sponsors:Daily Fitness Insider Newsletter: https://flex-diet.kit.com/bfa1510fa8Triphasic 2 book now available!Go to https://triphasic2.com/Episode Chapters:01:07 Exploring Microdosing: Benefits and Research01:56 Legal and Safety Considerations02:45 Personal Experiences with Psychedelics04:05 Microdosing Protocols and Effects17:13 Microdosing for Enhanced Performance29:22 The Role of Coaching in Neuroplasticity29:40 Microdosing and Moral Implications30:20 Understanding Neuroplasticity with Psychedelics34:06 Microdosing for Chronic Pain34:58 Microdosing vs. Pharmaceuticals36:54 Real-Life Evidence and Research47:43 Potential Risks of Microdosing51:51 Microdosing Community and Resources54:23 Conclusion and Final ThoughtsFlex Diet Podcast Episodes You May Enjoy: Episode 162: Aaron Rodgers ayahuasca retreat, performance, and research – a solocast by Dr Mike T Nelson Episode 111: My Plant Medicine Experience w Ayahuasca and Kambo in Costa RicaConnect with : Microdosing for Health, Healing and Advanced Performance: https://www.amazon.com/Microdosing-Health-Healing-Enhanced-Performance/dp/1250355583Dr James Fadiman: https://www.jamesfadiman.com/Jordan Gruber: https://jordangruber.com/Get In Touch with Dr Mike:Instagram: https://www.instagram.com/drmiketnelson/YouTube: https://www.youtube.com/channel/UCn1aTbQqHglfNrENPm0GTpg

Ellen Kamhi talks with Dr. Irene de Caso, a biologist who first specialized in neurobiology and then completed a master's of science and a doctorate in cognitive neuroscience and neuro-imaging from the University of York. A co-organizer of the 2020 Interdisciplinary Conference on Psychedelic Research and co-director of the Madrid Psychedelic Society, she lives in Madrid, Spain, where she works as a neuroscientific consultant and is studying to become a clinical psychologist. She is the author of "Psychedelics and Mental Health: Neuroscience and the Power of Psychoactives in Therapy."

Researchers are studying psychedelics as a possible treatment for conditions like depression, PTSD and substance use disorders. But they don't know exactly how these drugs work. Getting the answer to this question is especially difficult when people often take psychedelics like LSD and psilocybin for the "trip." This week on Short Wave, we're talking to researchers about how they're trying to untangle the effects of this "trip" from the ways psychedelics might change the human brain ... and why the answer could help direct the future of psychedelic research. Catch the rest of this series on psychedelics and related drugs this week by following us on Spotify and Apple Podcasts. Have other questions about psychedelics and the brain? Let us know by emailing shortwave@npr.org! Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Dr Peter Sjöstedt-Hughes is a Philosopher of Mind and Metaphysics who specializes in the thought of Whitehead, Nietzsche, Bergson, and Spinoza—and in fields pertaining to panpsychism, pantheism, mental causation, and altered states of consciousness. He is a lecturer at The University of Exeter. Peter is the author of Noumenautics (2015), Modes of Sentience (2021), co-editor and contributor of Bloomsbury's Philosophy and Psychedelics (2022), the TEDx Talker on ‘psychedelics and consciousness‘, and he is inspiration to the recreation of inhuman philosopher Marvel Superhero, Karnak. TIMESTAMPS:(0:00) - Introduction (1:00) - The Mind-Body Problem(4:00) - Idealism vs Panpsychism(6:45) - Defining Consciousness (15:30) - Spinozism & Whiteheadian Panpsychism(19:30) - Kastrup's Analytic Idealism(24:07) - Naïve Realism(29:30) - Huxley, James, Whitehead, Nietzsche, Spinoza, Schopenhauer, Bergson & Kant(35:15) - What is the Philosophy of Psychedelics?(41:38) - Evidence of Psychedelic Research(45:35) - Psychedelics & Consciousness(53:10) - Defining Psychedelics(59:50) - Metaphysical Shifts & Consensus Reality(1:04:30) - Peter's most Psychoactive Experience(1:09:40) - Psychedelic Research Criticism(1:13:14) - From Therapeutics to Metaphysics(1:16:18) - Mind At Large & Exogenous Mind Theory(1:23:08) - Free Will(1:27:40) - Panpsychisms(1:35:40) - Peter's Philosophical Heroes(1:40:02) - Final Thoughts(1:41:10) - Conclusion EPISODE LINKS:- Peter's Lecture: https://www.youtube.com/watch?v=f4yCrqS0dCY- Peter's Website: https://www.philosopher.eu/- Peter's X: https://twitter.com/PeterSjostedtH- Peter's Instagram: https://instagram.com/petersjostedth- Peter's LinkedIn: https://uk.linkedin.com/in/dr-peter-sjöstedt-hughes-2b7a2927- Peter's BlueSky: https://bsky.app/profile/petersjostedth.bsky.social- Peter's YouTube: https://youtube.com/@Ontologistics- Peter's Analytic Idealism Critique: https://www.feedyourhead.blog/p/flights-in-the-mindscapeCONNECT:- Website: https://tevinnaidu.com - Podcast: https://creators.spotify.com/pod/show/mindbodysolution- YouTube: https://youtube.com/mindbodysolution- Twitter: https://twitter.com/drtevinnaidu- Facebook: https://facebook.com/drtevinnaidu - Instagram: https://instagram.com/drtevinnaidu- LinkedIn: https://linkedin.com/in/drtevinnaidu=============================Disclaimer: The information provided on this channel is for educational purposes only. The content is shared in the spirit of open discourse and does not constitute, nor does it substitute, professional or medical advice. We do not accept any liability for any loss or damage incurred from you acting or not acting as a result of listening/watching any of our contents. You acknowledge that you use the information provided at your own risk. Listeners/viewers are advised to conduct their own research and consult with their own experts in the respective fields.

Send us a textIn this episode of Causes or Cures, Dr. Eeks sits down with Benjamin Lightburn, CEO of Filament Health, to explore the key differences between natural and synthetic psychedelics—and why those differences matter. Ben breaks down how Filament Health develops its natural psychedelic medicines, shares insights from ongoing clinical trials with top academic institutions, and discusses the early results. He also explains how Filament plans to bring these treatments to market and what sets them apart in the rapidly growing psychedelic space.Ben is a pioneer in natural drug development, having co-founded Filament Health to create the first-ever safe, naturally derived psychedelic medicines for conditions like substance use disorder. With 15 clinical trials underway across North America and Europe and a business now valued at $210M, Filament is making waves in the industry. Before this, Ben built and sold a successful natural extraction startup, Mazza Innovation, securing major deals with multinationals before its $26M acquisition.Tune in for a fascinating deep dive into the future of psychedelics—where nature meets science!You can contact Dr. Eeks at bloomingwellness.com.Follow Eeks on Instagram here.Or Facebook here.Or X.On Youtube.Or TikTok.SUBSCRIBE to her monthly newsletter here.Support the show

Watch every episode ad-free & uncensored on Patreon: https://patreon.com/dannyjones Travis Kitchens was a psychedelic research subject for Johns Hopkins University who eventually uncovered a secret plan to revive religion with drugs. Travis is currently a freelance journalist who writes extensively on the history and philosophy of psychedelic research. He lives in Kentucky. SPONSORS https://buy.ver.so/danny - Get 15% off your first order. https://hims.com/danny - Start your FREE online visit today. https://shopmando.com - Use code DANNY for $5 off your starter pack. https://whiterabbitenergy.com/?ref=DJP - Use code DJP for 20% off EPISODE LINKS Travis Substack - https://vegetabletelevision.substack.com The Most Controversial Paper in the History of Psychedelic Research - https://bit.ly/3WWoayH The Strange Case of The Immortality Key - https://bit.ly/42MzIIL FOLLOW DANNY JONES https://www.instagram.com/dannyjones https://twitter.com/jonesdanny OUTLINE 00:00 - Johns Hopkins' psychedelic study 08:22 - 'Robo-tripping' 17:00 - The Council on Spiritual Practices 25:30 - Can humans summon aliens? 43:33 - How the psychedelic renaissance started 56:11 - Did ancient mystery cults start Christianity? 01:01:25 - Graham Hancock vs Academia 01:11:30 - The fall of Christianity 01:20:47 - What happens to the brain on psychedelics 01:25:34 - MAPS 01:33:22 - The Catholic church is pushing drugs 01:38:10 - The Immortality Key: A New Reformation 01:42:59 - DARPA: Psychedelics on the battlefield 01:48:38 - Travis' weird email from Roland Griffiths 01:52:49 - MKUltra 2.0 01:57:36 - Reviving religion with Psychedelic drugs 02:15:16 - Secret unreleased psychedelic paper 02:24:33 - Who is funding psychedelic medicine research? Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode of the Sacred Stream Radio podcast, Laura speaks with Dr. Simon Ruffell. Simon is a psychiatrist and the founder and CEO of Onaya Science, an organization that conducts research into the effects of psychedelic plant medicine ceremonies on body, mind, and spirit. Onaya also offers a Psychedelic Mentorship Training program. Simon follows a collaborative approach to research that combines tradition with science, emphasizing the importance of listening to indigenous healers and including them in every step of the research process. Currently, Onaya is engaged in an ongoing five-year study of plant medicines for military veterans suffering from trauma. Onaya continues to develop research-backed programs and resources that combine traditional and modern models of care, with a commitment to holistic healing and interethnic collaboration for the benefit of individuals, communities, and the more-than-human world. You can learn more about Simon and Onaya at onaya.io.

In this episode, Joe interviews Josh Lipson, a Ph.D. candidate in clinical psychology at Columbia University, whose research explores the relationship between psychedelics, mystical experiences, and mental health. He discusses the complexities of studying psychedelics in real-world settings, the role of metaphysical perspectives in research, and why different individuals respond to psychedelics in such varied ways. Lipson shares his personal journey into psychedelic research, the challenges of interdepartmental collaboration, and the evolving landscape of modern psychedelic science. He also talks about: The importance of integration after psychedelic experience Why mystical experiences may not be the only path to healin The balance between stability and the chaos psychedelics can introduc The need for diverse perspectives and ways of knowing in psychedelic researc How psychedelics have shaped global consciousness and cultural perspectives and more! For links, head to the show notes page.

Dr. Robin Carhart-Harris is a leading neuroscientist and the founder of the Center for Psychedelic Research at Imperial College London, pioneering groundbreaking studies on the therapeutic potential of psychedelics for mental health. 15 Daily Steps to Lose Weight and Prevent Disease PDF: https://bit.ly/46XTn8f - Get my FREE eBook now! Subscribe to The Genius Life on YouTube! - http://youtube.com/maxlugavere Watch my new documentary Little Empty Boxes - http://littleemptyboxes.com This episode is proudly sponsored by: Momentous is a new supplement brand that holds its products to rigorous quality and purity standards set by the NFL and NBA. I use their creatine and protein regularly. Visit livemomentous.com/genius to get 20% off. AG1 is my favorite multivitamin. Enjoy a free 1 year supply of vitamin D and 5 free AG1 travel packs with your first purchase. All you have to do is visit drinkag1.com/GENIUS. Fatty15 provides C15:0, a naturally occurring fatty acid found in full-fat dairy that may support cellular health and longevity—get 15% off at http://fatty15.com/MAX with code MAX!

In this episode, Joe interviews renowned chemist, filmmaker, and journalist, Hamilton Morris.  After originally backing down from its first attempt in 2022, the DEA is once again looking to apply schedule I status to two lesser-known compounds: DOI (2,5-dimethoxy-4-iodoamphetamine) and DOC (2,5-dimethoxy-4-chloroamphetamine). For decades, DOI and DOC have been incredible tools for researchers studying serotonin receptors, showing promise for chronic pain, anxiety, depression, and more. Originally recorded as a livestream in November, we felt this discussion deserved more attention, as Morris was present during the hearing and saw first-hand the damage that can come from the combination of immense overreach and outdated beliefs. He talks about: The bureaucratic mess behind so much of what the DEA doe The safety profile and research capacity of DOI and DOC and complete lack of data showing recreational us The DEA's claim that advocates weren't expert The fight to protect the Sonoran Desert toad and more! While we wait for the conclusion of the hearing, head to Hamilton's Patreon to hear his daily breakdowns. For links, head to the show notes page. 

In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Dr. Robin Carhart-Harris at the inaugural Eudaimonia summit in West Palm Beach. Find full show notes and links here: https://thethirdwave.co/podcast/episode-287/?ref=278 As the founder of the world's first Centre for Psychedelic Research at Imperial College London and now the Ralph Metzner Distinguished Professor at UCSF, Dr. Carhart-Harris shares his research on how psychedelics affect the brain's default mode network. He explains the key differences between psychedelic therapy and traditional psychiatric medications, discusses his current studies examining the role of set and setting, and explores the unique properties of 5-MeO-DMT. The conversation weaves between detailed neuroscience, the challenges of integrating psychedelics into healthcare, and personal reflections on his 20-year commitment to advancing psychedelic research. Prof Carhart-Harris holds the Ralph Metzner Distinguished Professorship in Neurology and Psychiatry at University of California, San Francisco (UCSF), where he founded the Carhart-Harris Lab in 2023. His groundbreaking research includes human neuroimaging studies with LSD, psilocybin, MDMA, and DMT, along with clinical trials of psilocybin therapy for various disorders. He founded the world's first Centre for Psychedelic Research at Imperial College London in 2019. Named in TIME magazine's '100 Next' in 2021 and Vox Magazine's 'Future 50' in 2023, his current research at UCSF focuses on understanding the mechanisms of psychedelics and psychedelic therapy. Highlights: Origins and evolution of psychedelic research in neuroscience The role of default mode network in consciousness How psychedelics differ from traditional SSRIs The relationship between serotonin discovery and LSD research  Challenges of integrating psychedelic therapy into healthcare  Current research projects at UCS The unique properties of 5-MeO-DMT Personal reflections on 20 years in psychedelic research  Episode Link: Website Episode Sponsor: The Practitioner Certification Program by Third Wave's Psychedelic Coaching Institute.

We are excited to host Christopher Timmermann on this episode of the Mangu.tv podcast. Christopher Timmermann (PhD) obtained a BSc in Psychology in Santiago, Chile and an MSc in Cognitive Neuroscience at the University of Bologna in Italy. He is currently a post-doc at Imperial College London at the Centre for Psychedelic Research, where he leads the DMT Research Group. His empirical and theoretical work focuses on the neuroscience, psychiatry, psychology, and beliefs of psychedelics, their relationship to consciousness and applications in mental health. The work he has led has been published in high-regarded journals and has been widely covered by mass media outlets. He also founded and is the director of an educational non-profit in Chile, the ECOH Foundation. Christopher shares the story of his upbringing in Chile, eyesight issues and an interest in the mind led to his intellectual pursuit. He speaks about his studies in the neuroscience of DMT on the brain and mind. Chris explains what DMT is, debunking some of its myths and sharing some of his research discoveries. Giancarlo and Christopher discuss ways that society can integrate psychedelics, looking at legality and serving psychedelics outside the medical system for therapeutic reasons, and human development, such as couples therapy.  Chris speaks about the new research centre at UCL and intentions to propel new avenues of exploration in psychedelics for insight and creativity, particularly in outdoor and natural settings, as they are taken in indigenous environments.

Will Microdosing Enhance Your Personal and Professional Growth?   In this episode of the Longevity podcast, I am joined by Paul Austin, a leading expert on microdosing and psychedelics to discuss the world of performance enhancement, neuroplasticity, and how both psilocybin and LSD can play unique roles in personal growth and mental health. We also discuss the broader implications of psychedelic use and the promising research surrounding their therapeutic potential. Paul Austin is a visionary entrepreneur and a leading voice in the realm of psychedelic education and microdosing. As the founder of the educational platform Third Wave, Paul has been dedicated to exploring the burgeoning frontier of psychedelics to enhance cognitive performance, mental health, and overall well-being. Paul continues to push the boundaries of what's possible through mindful and informed psychedelic use and is truly at the forefront of reimagining how we approach mental and emotional wellness in the 21st century.   Thank you to our sponsors for making this episode possible: Manukora: Discover the benefits of premium Manuka honey with Manukora at http://manukora.pxf.io/kO0rJN.  Young Goose: Get 10% off your first order with code NAT10 at https://www.younggoose.com/?sca_ref=4464009.kEvuKfs1CO and save on future orders with code 5NAT at https://www.younggoose.com/?sca_ref=1194545.1x50tznxez. BEAM Minerals: Go to https://www.beamminerals.com code NAT20 to get 20% off your order   Find more from Paul Austin: Website: https://thethirdwave.co/ Facebook: https://www.facebook.com/thirdwaveishere Twitter: https://twitter.com/thirdwaveishere Instagram: https://www.instagram.com/paulaustin3w/?hl=en    Find more from Nathalie: YouTube: https://www.youtube.com/channel/UCmholC48MqRC50UffIZOMOQ  Join Nat's Membership Community: https://www.natniddam.com/bsp-community  Sign up for Nats Newsletter: https://landing.mailerlite.com/webforms/landing/i7d5m0  Instagram: https://www.instagram.com/nathalieniddam/  Website: www.NatNiddam.com    Facebook Group: https://www.facebook.com/groups/biohackingsuperhumanperformance    What We Discuss: 00:24 Paul's Journey to Portugal 03:14 Early Life and First Encounters with Cannabis 04:44 Exploring Psychedelics and Their Impact 07:00 The Birth of Third Wave 10:05 The Resurgence of Psychedelic Research 14:44 Understanding Different Psychedelics 22:02 Microdosing: Benefits and Practices 30:43 Microdosing LSD for Enhanced Focus and Creativity 31:58 Comparing LSD and Psilocybin: Effects and Uses 33:35 Combining Psilocybin with Other Supplements 34:41 The Stamets Stack: A Powerful Combination 38:21 Microdosing Protocols and Personal Experiences 41:45 Psychedelics and Neurodegenerative Diseases 51:51 Microdosing for Chronic Diseases and Mental Health 57:37 Resources and Programs for Psychedelic Coaching Key Takeaways: Microdosing with psychedelics like psilocybin mushrooms and LSD for enhancing neuroplasticity, improving focus, creativity, and emotional well-being. There is anecdotal and emerging research evidence that psychedelics might help with chronic conditions like Lyme disease, long COVID, and mold toxicity Psilocybin is valuable for emotional processing and therapy, while MDMA is on the cusp of FDA approval for treating PTSD

Send us a textIn this episode of Causes or Cures, Dr. Eeks chats with Dr. Lorenzo Pasquini and Hannes Kettner about their groundbreaking research on the effects of psychedelics in older adults. They delve into their shared interest in exploring psychedelics as a potential avenue for improving mental health and well-being in this population, where better treatments are urgently needed. The conversation covers the research process, details about the psychedelic retreats attended by participants, and the substances used. They also share key outcomes related to participants' well-being and discuss exciting future directions for their work.Dr. Pasquini is Assistant Professor of Neurology at UCSF whose research focuses on the brain's role in emotional states and social behavior. Using neuroimaging and neurophysiological techniques, he explores how these systems change with aging, neuropsychiatric diseases, and novel interventions like psychedelics. Hannes Kettner is a researcher and PhD candidate at the Centre for Psychedelic Research, Department of Brain Sciences at Imperial College, London. This episode is sponsored by Greco Gum, the all-natural chewing gum for your mouth and gut that is made from only ONE ingredient! Visit GrecoGum.com and use code ERIN15 to get 15% off your first order.*New* SUBSCRIBE for the Causes or Cures+ Bonus Episodes (now posted) & Monthly Live Q&As! You can contact Dr. Eeks at bloomingwellness.com.Follow Eeks on Instagram here.Or Facebook here.Or X.On Youtube.Or TikTok.SUBSCRIBE to her monthly newsletter here.Support the show

We are excited to host David Luke, for an episode on the Mangu.tv podcast series.  Dr David Luke is Associate Professor of Psychology at the University of Greenwich where he has been teaching an undergraduate course on the Psychology of Exceptional Human Experience since 2009, and he is also Honorary Senior Lecturer at the Centre for Psychedelic Research, Imperial College. His research focuses on transpersonal experiences, anomalous phenomena and altered states of consciousness, especially via psychedelics, having published more than 100 academic papers in this area, including thirteen books, most recently: Breaking Convention: A Seismic Shift in Psychedelia (2022) and DMT Entity Encounters (2021. When he is not running clinical drug trials with LSD, doing DMT field experiments or observing apparent weather control with Mexican shamans, he directs the Ecology, Cosmos and Consciousness salon. He is a co-founder and trustee of Breaking Convention: International Conference on Psychedelic Consciousness. He has given over 400 invited public lectures and conference presentations; won teaching, research and writing awards; organised numerous festivals, conferences, symposia, seminars, retreats, expeditions, pagan cabarets and pilgrimages; and has studied techniques of consciousness alteration from South America to India, from the perspective of scientists, shamans and Shivaites. He lives life on the edge of Sussex. David speaks about his upbringing, experimenting with psychedelics, shamanism, parapsychology, entheobotany, and his PhD thesis on the psychology of luck. Giancarlo and David discuss synchronicities, the double-slit experiment and the power of thought.

In this episode, David interviews Floris Wolswijk: senior project manager at Delphi; co-founder of FLO coaching; and founder of Blossom, an online informational hub collecting psychedelic courses, trials, companies, and over 2000 categorized research articles. When Wolswijk began Blossom, he was barely able to fill a weekly newsletter, and now he's adding a new study nearly every day, perfectly illustrating the exponential growth in psychedelic research. He talks about why so much research is happening (and why more isn't), the trends he's seen, the benefit in research changing people's minds, and what he hopes for in the future. What can the research community learn from existing real world evidence, and how can retreat centers and underground communities contribute? He also discusses: What culture is like in the Netherlands, where psilocybin truffles are legal Drug development and the possibilities of adjusting existing molecules What we can learn from the Lykos and FDA situation The economics of psychedelics and how insurance will likely be the next big conversation His work with FLO coaching, and how coaching, acceptance and commitment therapy, and psilocybin can work together and more!  For links, head to the show notes page. 

Trinity College is hosting Ireland's first psychedelic research conference today. To hear what will feature at this conference we spoke to Dr Kathryn Leddin, who is a member of Trinity College Dublin Psychedelic Research Group.

The Healing Journey of Psilocybin with Tara Portelli Tara Portelli CNHP, CHN, CHt, PCP(Psilocybin Guide, Founder) As founder of Arcadia Healing Sanctum, Tara Portelli has incredible success with her work in the field of Psilocybin Therapy in the retreat setting. She has had the opportunity to work with many high profile clients such as the Comptroller for many UK Ambassadors, a top Robotics Surgeon and numerous medical professionals including, doctors, surgeons, nurses, from all over the world. Her work has extended to first responders, war veterans and people who have limited success with conventional treatments. As founder of Arcadia Healing Sanctum, the reputation her organization has withheld has been recognized by the prestigious, Imperial College of London and now has become an affiliate organization, supporting ongoing research in the field of Psychedelics for mental health. Tara stumbled into her experience with Psilocybin, while on a self healing journey in Tulum, Mexico. As a former Paramedic who has suffered with PTSD, anxiety and some depression, she didn't even know how deep her pain was, until she had her first full dose of Psilocybin. Her experience left her with a deep sense of self and a feeling of peace that she had never experienced before. Working in Emergency services for 9 years, she saw an increasing rise in mental health and human suffering, as people become prisoners of their own minds and we enter into a “mental health crises”. She started working with this medicine under the guidance of a mushroom healer and began helping others through their own journeys to healing. She studied Psychology and Cultural Anthropology at the University of Calgary and then went on to train in Paramedicine, holding a A-EMCA, license as a Primary Care Paramedic (PCP), practising for nine years. In addition, she holds a credentials as a Certified Natural Health Professional (CNHP), Certified Holistic Nutritionist (CHN) and as a Clinical Hypnotist (CHt), training under renowned psychotherapist, Debbie Papadakis. She is has the ability of helping people dive deep into the subconscious mind and healing the relationship with the true self, as well as healing trauma. She has experience working in a Private Holistic treatment facility for mental health and addictions, as well as a family history of mental illness, creating a very deep and passionate affinity for her work. Tara understands psilocybin and the function it can play on a physiological level. In 2020, she aligned herself with Therapsil, a non-profit organization, advocating for Psilocybin therapy for terminal patients who were suffering from end-of-life distress. She was part of the team that successfully gained the first legal access to Psilocybin for terminal patients in Canada. In the right setting, dose and space, this medicine can offer a very life changing experience to those in need. Tara holds a loving, warm and very safe space for those who are ready to take this journey. Website:

With mounting evidence for the effectiveness of psychedelic assisted therapies in treating a range of disorders, organisers are advocating for this therapy to be made an HSE funded, publicly available treatment. With Dr Colm Harrington, chair of Irish Doctors for Psychedelic-Assisted Therapy.

Welcome back to The Trip Report Podcast, a production of Beckley Waves.Today's conversation is with Shamil Chandaria, and as I alluded to in last week's newsletter introducing computational neuroscience—it is the longest and most technical conversation we've had to date.I have wanted to speak with Shamil since I watched his lecture at Oxford titled The Bayesian Brain and Meditation.Shamil is a former advisor to Google DeepMind, co-foudner and research fellow at Imperial College London Centre for Psychedelic Research and Oxford University's Centre for Eudaimonia and Human Flourishing, and a co-author with Robin Carhart-Harris and the Imperial team of the influential 2023 paper titled Canalization and Plasticity in Psychopathology, Importantly for this conversation, Shamil is also a longtime meditation practitioner, and his current work is dedicated to exploring contemplative practices, spiritual awakening, and psychedelics through the lens of computational neuroscience. At the heart of the conversation is the Free Energy Principle, a relatively new concept in cognitive neuroscience that conceives of the brain as a prediction machine constantly updating its internal models to minimize prediction errors. This framework along with the Bayesian Brain Hypothesis show how the brain optimally processes sensory data through inference, which has profound implications for how we perceive and experience the world.We discuss:* The brain as a prediction machine* The convergence of ancient wisdom and modern neuroscience.* Defining human flourishing beyond the absence of suffering to include meaning, love, joy, connection, and psychological resilience.* The role of body sensations, emotions, and somatic practices in psychotherapy and how they tie into the brain's predictive coding mechanisms.* Spiritual awakening, liberation and human flourishing through a neurocomputational lens* The potential for integrating free energy principle-based models into the field of psychiatry, improving therapeutic approaches and mental health care.* And much moreMy takeaway from this conversation is that we are, in fact, in the midst of a paradigm shift—one that bridges the fields of meditation, psychology, psychedelics, phenomenology, psychiatry, and even artificial intelligence. This new understanding, grounded in the free energy principle, offers a unified theory that links ancient wisdom with modern neuroscience, reshaping how we think about consciousness, well-being, and what it means to be sentient.And now, I bring you my conversation with Shamil Chandaria.I want to highlight our friends at the Tiny Blue Dot Foundation (TBD), who have just announced their latest Request for Proposals for scientific studies of the Perception Box.Tiny Blue Dot Foundation strives to help people understand that they live in their own unique Perception Box whose walls can be expanded to minimize suffering, increase acceptance of self and others, and view trauma and other challenges as opportunities for growth.TBD has allocated $9,000,000 to fund up to 10 rigorous research projects related to The Science of the Perception Box. TBD ran similar RFPs over the last two years and funded a total of 23 projects thus far. Information about these projects can be found here and here.Listen to the episode on Substack, Spotify, Google or Apple.Credits:* Hosted by Zach Haigney * Produced by Zach Haigney, Erin Greenhouse, and Katelin Jabbari* Find us at thetripreport.com* Follow us on Instagram, Twitter, LinkedIn and YouTubeTheme music by MANCHO Sounds, Mixed and Mastered by Rollin Weary This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thetripreport.com

This week on the podcast previous guest Shamil Chandaria is returning to discuss his recent paper “A beautiful loop: An active inference theory of consciousness”, co-authored with Ruben Laukkonen. Shamil Chandaria is an expert in artificial intelligence and computational neuroscience. He was a founder of the Centre for Psychedelic Research at Imperial College London where he is a Research Fellow, as well as at The School of Advanced Study's Institute of Philosophy, which is part of the University of London. He is a Senior Research Fellow at the Centre for Eudaimonia and Human Flourishing at Oxford University, and, most recently, he became a fellow of Fitzwilliam College at Cambridge university. https://osf.io/preprints/psyarxiv/daf5n

Adele Lafrance PhD is a clinical psychologist, research scientist, author and developer of emotion-focused treatment modalities, including Emotion-Focused Family Therapy for eating disorders. She is also active in the research and practice of psychedelic medicine, with a focus on ayahuasca, MDMA, psilocybin and ketamine. Adele was the Strategy Lead for the MAPS-sponsored study of MDMA-assisted psychotherapy for eating disorders and a clinical trainer and supervisor for Imperial College Center for Psychedelic Research. She has a particular interest in mechanisms of healing, including emotion processing, spirituality, love, and family-based psychedelic medicine.   We discuss topics including: How Adele became interested in psychedelics and eating disorders Her first experience with psychedelics Ketamine optimizes the brain condition  What psychedelics can show us The importance of the caretaker, partner and/or guardian to have training when their loved one returns from treatment with psychedelics   SHOW NOTES: www.dradelelafrance.com https://www.oprahdaily.com/life/health/a60652844/psychedelics-treatment-for-eating-disorders/ ____________________________________________ If you have any questions regarding the topics discussed on this podcast, please reach out to Robyn directly via email: rlgrd@askaboutfood.com You can also connect with Robyn on social media by following her on Facebook, Instagram, Twitter, and LinkedIn. If you enjoyed this podcast, please leave a review on iTunes and subscribe. Visit Robyn's private practice website where you can subscribe to her free monthly insight newsletter, and receive your FREE GUIDE “Maximizing Your Time with Those Struggling with an Eating Disorder”. Your Recovery Resource, Robyn's new online course for navigating your loved one's eating disorder, is available now! For more information on Robyn's book “The Eating Disorder Trap”, please visit the Official "The Eating Disorder Trap" Website. “The Eating Disorder Trap” is also available for purchase on Amazon.

In this week's episode, we welcome Dr. Shamil Chandaria, a philanthropist, entrepreneur, technologist, and academic with interdisciplinary research interests spanning computational neuroscience, artificial intelligence, and the philosophy and science of human wellbeing. His PhD from the London School of Economics focused on the mathematical modeling of economic systems, and he later earned an MA in philosophy from University College London. Here, he developed an interest in the philosophy of science and explored philosophical issues in biology, neuroscience, and ethics. In 2018, Shamil contributed to founding the Global Priorities Institute at Oxford University—an interdisciplinary research center addressing humanity's most pressing issues. The following year, he co-founded the Centre for Psychedelic Research in the Department of Brain Sciences at Imperial College London, which investigates psychedelic therapies for conditions like treatment-resistant depression. He has also supported research on the neuroscience of meditation at Harvard and the University of California, Berkeley. Shamil is not only a brilliant mind but also a person with a great, open heart, whose smile and enthusiasm are infectious. In our conversation, we discuss the intersections between spirituality, meditative practices, and neuroscience—how the latest brain science connects spiritual experiences with emerging understanding in the field. Shamil introduces the ‘free energy' approach—a paradigm developed over the last 15 years in neuroscience, also known as predictive processing or active inference. We look into questions such as: Why does conscious experience exist at all? What is the brain's goal in experiencing? How do neurotransmitters function? What role does the self play? Why do we get to act as we do? How does this model interact with the tantric view of reality? And many more topics. Read Ruben Laukkonen & Shamil Chandaria's latest paper: A beautiful loop: An active inference theory of consciousnessDiscover a treasure trove of guided meditations, teachings, and courses at tantrailluminated.org. Hosted on Acast. See acast.com/privacy for more information.

NewsIntroducing OpenAI o1 - a new series of reasoning models for solving hard problemsApple Event - September 9 (syde)Apple Event HighlightsApple Intelligence will not be available in the EU or China Justice Department Sues RealPage for Algorithmic Pricing Scheme that Harms Millions of American Renters / 10 Best Competitive Pricing Tools for B2B and B2C CompaniesHow Lidl accidentally took on the big guns of cloud computingAmazon turns to Anthropic's AI for Alexa revampInspiration#EVENT :: ALPS Conference 2024 The Swiss Academic Conference on Psychedelic Research and Therapy 11 - 12 October 2024 Aarau, Switzerland#BOOK :: The Seven Principles for Making Marriage Work by John GottmanThe Tyranny of Metrics: Muller, Jerry Z #PODCAST :: All-In Summit videos#QUOTE :"I am not what happened to me, I am what I choose to become." by Carl Gustav Jung Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

One of your favorite series is back with a name change Welcome to the first episode of Micro-dose Mondays (Round Robins, just a different title)! In today's episode, your hosts Marianna and Tony will be tackling four smaller topics requested by their listeners. As always, this podcast is based on science and research.  Today your hosts will be discussing what happens when you don't eat enough, the difference between training to get stronger vs bigger, micro-dosing psychedelics, and the Kardashian supplement line.  All Training Programs: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Access to all complete 12-week training programs HERE⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ FS Premium: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sign up for Fitness Stuff PREMIUM here!!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Bonus episodes EVERY Friday answering your questions Weekly Legion supplement giveaways Access to ALL advanced 12-Week Training Programs Exclusive discounts to brands like Oura Ring, Marek Health, ⁠⁠⁠Examine.com⁠⁠⁠ Other resources: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Fitness Stuff Calculators (Calorie, Protein, etc.) ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Legion Athletics: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Take 20% off Legion Athletics Supplements with code “FSPOD” at checkout here.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ TIMESTAMPS: (04:20) Strength vs Size  (20:35) Consequences of not eating enough  (42:25) Micro-dosing Psychedelics (58:29) Lemme Supplements 

There is a lot of exciting research going on right now in the world of psychedelic medicine. So much, in fact, that it can be difficult to keep track of it all. Where do you go for reliable information? How do you interpret results? How is it that studies with similar hypotheses can have contradictory findings? In today's episode of the Psychedelic Therapy Frontiers podcast, we're going to discuss these questions while we walk you through a few studies that Reid and I found interesting. Expect to learn what psilocybin does to the brain, how psychedelic experiences affect death anxiety, how the therapeutic relationship influences outcomes in psychedelic-assisted therapy, whether or not remembering a psychedelic experience has a connection to positive mental health outcomes, and much more. For those of you who are new to the show, welcome! Psychedelic Therapy Frontiers is brought to you by Numinus and is hosted by Dr. Steve Thayer and Dr. Reid Robison.Learn more about our podcast at https://numinus.com/podcast/Learn more about psychedelic therapy training opportunities at https://numinus.com/training/Learn more about our clinical trials at https://www.numinus.com/clinical-trials Learn more about Numinus at https://numinus.com/Email us at ptfpodcast@numinus.com Follow us on Instagram: https://www.instagram.com/drstevethayer/https://www.instagram.com/innerspacedoctor/https://www.instagram.com/numinushealth/

Welcome to the Interdisciplinary Conference on Psychedelic Research! #ICPR24 In this episode, I sit down with Leanne Rowell, an inspiring figure from the UK who is making waves at the ICPR conference in the Netherlands. This is our first in-person meeting, and we dive into an engaging discussion about the evolving psychedelic space. Leanne shares her journey from the corporate world to becoming a guide in psychedelic community building. We explore the integration of psychedelic practices into everyday life, the importance of authenticity, and how psychedelics can enhance our roles in society. Join us for this insightful conversation about bridging traditional corporate roles with the transformative potential of psychedelics. About Leanne: A devoted wife and mother of two, who has journeyed through various roles in her life. She began her career as an accountant before embracing her calling as a teacher. Now, she proudly holds the title of UNIO's Connection Alchemist. Born in South Africa, Leanne has lived in London and Nairobi, and now she and her family have found their haven in a converted 18th Century barn in East Sussex, UK. An avid traveler, both in the physical and metaphysical realms, Leanne finds her bliss in the African bush. Known for her ability to devour books in a single sitting, she may not excel at housekeeping, but she has a remarkable talent for planning unforgettable holidays. Connect with Leanne: Facebook: https://web.facebook.com/leasteward Thank you so much for joining us! Psychedelic Conversations Podcast is designed to educate, inform, and expand awareness. For more information, please head over to https://www.psychedelicconversations.com Please share with your friends or leave a review so that we can reach more people and feel free to join us in our private Facebook group to keep the conversation going. https://www.facebook.com/groups/psychedelicconversations This show is for information purposes only, and is not intended to provide mental health or medical advice. About Susan Guner: Susan is a trained somatic, trauma-informed holistic psychotherapist with a mindfulness-based approach grounded in Transpersonal Psychology that focuses on holistic perspective through introspection, insight, and empathetic self-exploration to increase self-awareness, allowing the integration of the mind, body and spirit aspects of human experience in personal growth and development. Connect with Susan: Website: https://www.psychedelicconversations.com/ Facebook: http://www.facebook.com/susan.guner LinkedIn: https://www.linkedin.com/in/susan-guner/ Instagram: http://www.instagram.com/susanguner Twitter: http://www.twitter.com/susanguner Blog: https://susanguner.medium.com/ Podcast: https://anchor.fm/susan-guner #PsychedelicConversations #SusanGuner #LeanneRowell

Welcome to the Interdisciplinary Conference on Psychedelic Research! #ICPR24 In this episode of Psychedelic Conversations, I sit down with Cody Wenthur, an assistant professor from the University of Wisconsin's School of Pharmacy. Recorded at the ICPR 24 conference in Haarlem, Netherlands, we delve into Cody's motivations for entering the psychedelic research field, driven by his fascination with how small molecules can significantly alter human behavior. We explore the unique master's program at his school, which focuses on psychoactive pharmaceutical investigation, preparing students to navigate the regulatory process for brain-active molecules. Cody shares insights from the conference, discusses regulatory developments in Europe, and highlights the importance of education in advancing the field of psychedelic studies. Join us for an enlightening discussion on the intersections of science, education, and psychedelics. About Cody: From his earliest days in the laboratory, he's been particularly interested in questions that give a better picture of how the brain turns external stimuli into lasting decisions and driven by the vision of using the answers to try to improve human mental health. Cody honed this translational ethos during his training at Purdue, Vanderbilt, and Scripps, which included clinical work in inpatient psychiatric units, mechanistically novel academic drug discovery efforts, and the search for biomarkers of response to vaccines directed against abusable psychoactive substances. Cody is directing a group of talented, curious individuals from both clinical and basic science backgrounds, and he is relishing the unexpected insights and challenges that arise as he works through forward-looking problems at the interface of chemistry, neuroscience, physiology, and pharmacology. Whether through development of vaccines directed against synthetic psychoactive drugs, pharmacologic dissection of rapidly acting antidepressant activity, or manipulation of psychedelic-assisted psychotherapy context, current projects in his lab ultimately focus on maximizing the benefits and minimizing the harms arising from chemically induced mechanisms of long-term behavioral change. Connect with Cody: Email: wenthur@wisc.edu Twitter: https://x.com/wenthurlab?s=21&t=yQZ5Nn9I3PFK-NVgLsjHjA LinkedIn: https://www.linkedin.com/in/cody-wenthur?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=ios_app Thank you so much for joining us! Psychedelic Conversations Podcast is designed to educate, inform, and expand awareness. For more information, please head over to https://www.psychedelicconversations.com Please share with your friends or leave a review so that we can reach more people and feel free to join us in our private Facebook group to keep the conversation going. https://www.facebook.com/groups/psychedelicconversations This show is for information purposes only, and is not intended to provide mental health or medical advice. About Susan Guner: Susan is a trained somatic, trauma-informed holistic psychotherapist with a mindfulness-based approach grounded in Transpersonal Psychology that focuses on holistic perspective through introspection, insight, and empathetic self-exploration to increase self-awareness, allowing the integration of the mind, body and spirit aspects of human experience in personal growth and development. Connect with Susan: Website: https://www.psychedelicconversations.com/ Facebook: http://www.facebook.com/susan.guner LinkedIn: https://www.linkedin.com/in/susan-guner/ Instagram: http://www.instagram.com/susanguner Twitter: http://www.twitter.com/susanguner Blog: https://susanguner.medium.com/ Podcast: https://anchor.fm/susan-guner #PsychedelicConversations #SusanGuner #CodyWenthur #ICPR24

Welcome to the Interdisciplinary Conference on Psychedelic Research! #ICPR24 In this episode, we discuss the intersection of psychedelics, philosophy, and technology with Alexander Bard, a renowned philosopher from Stockholm. Alex shares his journey from the music industry to becoming a social philosopher and author. We delve into how psychedelics influence creativity and philosophical ideas, exploring their therapeutic and spiritual benefits. Alex emphasizes the importance of integrating psychedelic experiences within a structured and professional context, highlighting the roles of psych analysis and mediation. We also touch on the historical use of psychedelics by prominent philosophers and the critical distinction between psychological and psychoanalytical approaches. Join us for this enlightening conversation at ICPR24, where we explore the profound impact of psychedelics on human consciousness. About Alex: Alexander Bard is a philosopher, artist, songwriter and music producer, author of six books with Jan Söderqvist, living in Stockholm, Sweden. Bard built his career as a philosopher in parallel with a highly successful 25-years-plus career in the international music industry. Bard & Söderqvist's philosophy concentrates on the relationship between human beings and technology, using human beings as the constant throughout civilization, with technology as the ever faster changing variable. Their work takes inspiration from thinkers like Hegel, Nietzsche, Whitehead, Deleuze, and Eastern philosophy and spirituality, in the latter case adding Persia to the well known triad of India, China and Japan. They are convinced philosophy will be the last human activity to ever be affected by AI. Connect with Alex: Website: http://syntheism.com/ Facebook: https://www.facebook.com/alexander.bard Speakersnet: https://speakersnet.se/speakers/alexander-bard/ Thank you so much for joining us! Psychedelic Conversations Podcast is designed to educate, inform, and expand awareness. For more information, please head over to https://www.psychedelicconversations.com Please share with your friends or leave a review so that we can reach more people and feel free to join us in our private Facebook group to keep the conversation going. https://www.facebook.com/groups/psychedelicconversations This show is for information purposes only, and is not intended to provide mental health or medical advice. About Susan Guner: Susan is a trained somatic, trauma-informed holistic psychotherapist with a mindfulness-based approach grounded in Transpersonal Psychology that focuses on holistic perspective through introspection, insight, and empathetic self-exploration to increase self-awareness, allowing the integration of the mind, body and spirit aspects of human experience in personal growth and development. Connect with Susan: Website: https://www.psychedelicconversations.com/ Facebook: http://www.facebook.com/susan.guner LinkedIn: https://www.linkedin.com/in/susan-guner/ Instagram: http://www.instagram.com/susanguner Twitter: http://www.twitter.com/susanguner Blog: https://susanguner.medium.com/ Podcast: https://anchor.fm/susan-guner #PsychedelicConversations #SusanGuner #AlexanderBard #ICPR24

Welcome to the Interdisciplinary Conference on Psychedelic Research! #ICPR24 In this episode, we delve into the history and mission of the Microdosing Institute, which has been a leading force in combining ancestral wisdom with modern science to promote safe and effective microdosing practices. Hein shares his personal journey with psychedelics, the importance of integrating high-dose experiences, and the evolving legal landscape in the Netherlands. We also discuss the significance of citizen science and the role of research in validating the benefits of psychedelics. Tune in to learn more about the transformative potential of these substances and how microdosing can aid in personal development. About Hein: Hein Pijnnaken is a Transformational Coach, NLP Master (advanced), and microdosing educator & coach. While growing up in the Netherlands—one of the most psychedelic-friendly countries in the world—he became familiar with psychedelics in his early college years and has used them as transformative tools ever since. Today, he has over 30 years of experience guiding psychedelic sessions and has immersed himself—both theoretically and practically —in the topic of microdosing since 2016. He strongly believes microdosing is an incredible tool for self-development, especially in combination with effective coaching. Connect with Hein: Website: https://microdosinginstitute.com Instagram: https://www.instagram.com/microdosinginstitute?igsh=OTVla2dybDR1MDZs LinkedIn: https://www.linkedin.com/in/hein-pijnnaken-73b479208?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=ios_app LinkedIn: https://www.linkedin.com/company/microdosing-institute/ Thank you so much for joining us! Psychedelic Conversations Podcast is designed to educate, inform, and expand awareness. For more information, please head over to https://www.psychedelicconversations.com Please share with your friends or leave a review so that we can reach more people and feel free to join us in our private Facebook group to keep the conversation going. https://www.facebook.com/groups/psychedelicconversations This show is for information purposes only, and is not intended to provide mental health or medical advice. About Susan Guner: Susan is a trained somatic, trauma-informed holistic psychotherapist with a mindfulness-based approach grounded in Transpersonal Psychology that focuses on holistic perspective through introspection, insight, and empathetic self-exploration to increase self-awareness, allowing the integration of the mind, body and spirit aspects of human experience in personal growth and development. Connect with Susan: Website: https://www.psychedelicconversations.com/ Facebook: http://www.facebook.com/susan.guner LinkedIn: https://www.linkedin.com/in/susan-guner/ Instagram: http://www.instagram.com/susanguner Twitter: http://www.twitter.com/susanguner Blog: https://susanguner.medium.com/ Podcast: https://anchor.fm/susan-guner #PsychedelicConversations #SusanGuner #HeinPijnnaken #ICPR24

Mona Sobhani, Ph.D. is a cognitive neuroscientist, researcher, and author. In 2022 she published her first book, Proof of Spiritual Phenomena: A Neuroscientist's Discovery of the Ineffable Mysteries of the Universe, which documents her “transformation from diehard materialist to open-minded spiritual seeker.” Mona joins the show to discuss blowing open the box of materialism, why anecdotes are scientifically underrated, what she learned from studying decades of research into psi-phenomena, how quantum science is transforming the way we think about consciousness, and MUCH more! Important Links: Mona's Twitter Proof of Spiritual Phenomena: A Neuroscientist's Discovery of the Ineffable Mysteries of the Universe; by Mona Sobhani Cosmos, Coffee & Consciousness (Mona's Substack) Life Will Be the Death of Me Podcast with Chelsea Handler (Ep. 19): People on the Other Side with Laura Lynne Jackson Infinite Potential: The Life & Ideas of David Bohm Prophetic AI Show Notes: Mona's Journey Beyond Materialism Anecdotes are Scientifically Underrated; Research Into Psi Phenomena How Mona Deals With Her Colleagues' Skepticism The Persuasiveness of Personal Experience Psychic Phenomena & the Scientific Method Blowing Open the Box of Materialism How Quantum Science is Transforming How We Think About Consciousness Transcendent Technology Psychedelics as a Bridge What's Next for Mona Bringing Humanity Back Into Science Mona as Empress of the World MORE! Books & Articles Mentioned: Proof of Spiritual Phenomena: A Neuroscientist's Discovery of the Ineffable Mysteries of the Universe; by Mona Sobhani The Radical Ideas of Psychedelic Research 2.0 (Pt.1; Pt.2); by Mona Sobhani Many Lives, Many Masters: The true story of a prominent psychiatrist, his young patient and the past-life therapy that changed both their lives; by Dr. Brian Weiss The New Inquisition: Irrational Rationalism and the Citadel of Science; by Robert Anton Wilson Personal Knowledge: Towards a Post-Critical Philosophy; by Michael Polanyi The Two Cultures; by C. P. Snow The Fabric of Reality: Towards a Theory of Everything; by David Deutsch The work of Dean Radin The Common Basis of Memory and Consciousness: Understanding the Brain as a Write-Read Head Interacting With an Omnipresent Background Field' by Joachim Keppler How To Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence; by Michael Pollan What the Tortoise Said to Achilles; by Lewis Carroll

Send us a Text Message.In today's episode, we dive deep into the transformative power of psychedelic-assisted therapy with award-winning strategic thinker and educator, Jill Sitnick. Join us as Jill shares her journey of overcoming childhood-induced PTSD through MDMA therapy. This episode is a must-listen for anyone interested in mental health, trauma recovery, and the future of psychedelic treatments.

In this episode, special guest host Court Wing interviews Monica Verduzco-Gutierrez, MD: professor and chair of rehabilitation medicine at UT Health San Antonio; Joel Castellanos, MD: co-founder and associate medical director of the Center for Psychedelic Research at UC San Diego; and MaryAnn Welke Lesage: a long COVID survivor who reports experiencing drastic improvement in symptoms after MDMA and psilocybin therapy. As the world slowly recovers from COVID, many people are seeing continued or new symptoms, and while much is still not understood, these symptoms are being categorized as long COVID: essentially a persistent viral inflammation causing brain fog, headaches, depression, and other hard-to-diagnose symptoms. With estimations of as many as 18% of people in the U.S. experiencing this at one point and 6.8% currently dealing with it, could psychedelics – which can decrease inflammation and reset neural networks – help alleviate these symptoms?  They discuss:  How long COVID fits into what we already know about psychedelics, pain, and inflammatory medicine Why MDMA or psilocybin therapy, specifically, can help The importance of physical medicine and rehabilitation (PM&R) and the myriad of tools these physicians have learned to work with Why anecdotal evidence matters towards future research and more!  For more info, read Lesage's article, "How Psychedelics Became Key to My Long COVID Recovery," as well as the official paper: "Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report." For more links, head to the show notes page.

One could argue that psychedelic research has experienced a similar journey as crypto, in the sense that decentralised communities bound together to fund research where centralised entities refuse to do so. One of the greatest hurdles in modern science is access to research funding, and DeSci aims to provide a solution through decentralised crowdfunding. In addition, IP rights are incontestably attributed with the help of blockchain technology, as they cannot be altered at a later date. However, as the human mind is unique and moulded by each individual's life story, establishing a causal relationship between consumption and their beneficial or detrimental effects can be extremely biased.We were joined by Dima Buterin & Paul Kohlhaas, to discuss the vast subject of psychedelics (especially in relationship to trauma), how research has progressed and how decentralisation pushes the field forward (DeSci).Topics covered in this episode:Dima's & Paul's backgroundsDiscovering psychedelicsDealing with traumaPsychedelics throughout history and societiesHow Molecule DAO was foundedDeSci & on-chain IPEthereum early days, causality & rationalityPsyDAONetwork statesMiscEpisode links:Dima Buterin on TwitterPaul Kohlhaas on TwitterMolecule DAO on TwitterPsy DAO on TwitterSponsors:Gnosis: Gnosis builds decentralized infrastructure for the Ethereum ecosystem, since 2015. This year marks the launch of Gnosis Pay— the world's first Decentralized Payment Network. Get started today at - gnosis.ioChorus1: Chorus1 is one of the largest node operators worldwide, supporting more than 100,000 delegators, across 45 networks. The recently launched OPUS allows staking up to 8,000 ETH in a single transaction. Enjoy the highest yields and institutional grade security at - chorus.oneThis episode is hosted by Brian Fabian Crain.

Jules Evans is the author of four books, director of the Challenging Psychedelic Experiences Project, and editor of Ecstatic Integration.Episode Highlights▶ Jules's journey with psychedelics, stoicism, and how he became a writer▶ The work that Jules does with The Challenging Psychedelic Experiences Project▶ Insights and research into difficult psychedelic experiences▶ The truth about the abuse and misuse in the psychedelic community▶ The need for accountability and support in the industry ▶ The challenges of underground therapy and the risks of unregulated practices▶ The ethics of therapist-patient relationships ▶ The importance of informed consent in healing practices▶ The future of the psychedelic industry  Jules Evans's Links & Resources▶ Website:  www.ecstaticintegration.org▶ Twitter: https://twitter.com/julesevans11▶ Instagram: https://instagram.com/julesthephilosopher Download Beth's free business trainings here: Integrating Psychedelics & Sacred Medicines Into a Transformational Business:https://bethaweinstein.com/psychedelics-in-businessClarity to Clients: Start & Grow a Transformational Coaching, Healing, Spiritual, or Psychedelic Business https://bethaweinstein.com/grow-your-spiritual-business ▶ Beth's Programs & Courses: https://bethaweinstein.com/services▶ Beth on Instagram: http://instagram.com/bethaweinstein▶ Beth Weinstein on Facebook: https://www.facebook.com/bethw.nychttps://www.facebook.com/BethWeinsteinbiz▶ Join the free Psychedelics & Purpose Community: https://www.facebook.com/groups/PsychedelicsandSacredMedicines

In this episode of the Psychedelic Medicine Podcast Tommaso Barba joins to explore the topic of psychedelics for sexual functioning and intimacy. Tommaso is a PhD candidate at the Centre for Psychedelic Research at Imperial College London where his research is focused on understanding the potential role of psychedelic drugs for well-being. Tommaso authored the first paper on the effects of psychedelics on sexual functioning. In this conversation, Tommaso shares results from the multiple studies into psychedelics and sexual functions he has been involved in. He reports that in both a trial comparing psilocybin and escitalopram and a survey of naturalistic psychedelic use, respondents reported positive impacts on sexual functioning following psychedelic experiences. He also speculates about aspects of the psychedelic experience that are interpreted as “erotic” in the midst of the altered state and the reported shifts to experiencing sexual connection as more “spiritual” following psychedelic experiences. In closing, Tommaso discusses the promise of psychedelic journeys for healthy couples and the difficulties of researching this topic since there is no clear pathology being addressed.    In this episode you'll hear: How Tommaso got interested in the intersection of psychedelics and sexual functioning Why SRRIs often have side effects of inhibiting sexual function How psychedelic neuropharmacology may help explain improved sexual functioning following psychedelic experiences The upcoming studies exploring the effects of psychedelic journeys on couples who undergo the experience together The possible differences between MDMA and classic psychedelics in terms of mechanism and impact when it comes to effects on sexual function   Quotes: “When we looked at the positive affect symptoms—like wellbeing, connectedness, ability to feel emotions, and so on… Psilocybin outperformed escitalopram. And given so, we were really curious to investigate further the sex lives of these patients, because an active sex life is a key component of people's wellbeing, and a very overlooked one.” [7:34] “What we found was that people treated with psilocybin reported improvements in sexual pleasure, in capacity to communicate sexual desires with their partner, in sexual arousal, sexual satisfaction, and similar components of sexual functioning, while people treated with escitalopram did not report any of these changes and tended to report deterioration in this aspect of functioning.” [11:10] “[These psychedelic treatments may] work because it disentangles couples and its capable of individuating the two patients into the context of their relationship so that they start to develop a better identity in the context of the relationship instead of being completely fused into each other and not capable of really developing themselves and communicating their desires and what they want.” [31:15]   Links: Tommaso on Twitter Tommaso on LinkedIn Imperial College Centre for Psychedelic Research online survey study: psychedelics and couples Previous episode: Microdosing and the Placebo Effect with Balázs Szigeti, PhD Psychedelic Medicine Association Porangui

In this new episode, experts explore the burgeoning field of psychedelic psychiatry, highlighting the transformative potential of guided psychedelic experiences, personal narratives of dedication and curiosity among pioneers, the challenges of integrating psychedelics into clinical practice responsibly, and the broader ethical considerations. It also touches on technological innovations like artificial intelligence in mental health care. Overall, the conversation offers a glimpse into a future where unconventional therapies and cutting-edge technologies redefine mental health treatment with compassion and innovation.Host: Bruce Bassi MDMore resources, including a full transcript, can be found at our podcast website: https://www.telepsychhealth.com/futurepsychiatrypodcast/We are always looking to grow and learn more about the field of tech and mental health. If you have an idea for the show, want to suggest a guest, or have a suggestion, please feel to message us through our website's contact page. If you want to support the show, please like on Facebook, and follow us on Instagram, and Tiktok and subscribe on Youtube.As always, the content is for educational purposes and is not medical advice. If you are having a medical or psychiatric emergency please contact 911.

Dr. Charles Nemeroff is Chair of the Department of Psychiatry and Behavioral Sciences at the University of Texas-Austin's Dell Medical School. He is also co-director of the Center for Psychedelic Research and Therapy, and director of the Institute for Early Life Adversity Research. His research is focused on the pathophysiology of mood and anxiety disorders with a focus on the role of child abuse and neglect as a major risk factor.00:00 Introduction00:52 Dr. Nemeroff's Research Journey01:55 Childhood Maltreatment as Risk Factor04:53 Advances and Challenges in Precision Psychiatry07:33 Psychedelic Medicine (incl. blinding issues and potential adverse events)20:50 How Psychedelics Disrupt the "Circle of Hell"30:00 Psilocybin as Potential Treatment for Anorexia Nervosa38:32 Screening for Childhood Maltreatment41:30 Transcranial Magnetic Stimulation (TMS)44:14 Focused Ultrasound46:32 Prescribing MAOIs49:34 ConclusionVisit our website for more insights on psychiatry.Podcast producer: Jon Earle

What happens when we explore the intersection of psychedelic medicines and healing? In this episode, Dr. Dave Rabin and Dr. Jeff Chen embark on a journey through the landscape of psychedelic drugs, from their historical roots in America's counterculture to their re-examination for therapeutic purposes today. Delving into the challenges of conducting research on psychedelic substances, particularly under regulatory restrictions, they shed light on the potential of cannabis for psychedelic-assisted therapy. Join them as they discuss the evolving field of psychedelic research, touching on crowd-sourced studies, decriminalization, and the crucial integration of therapy with psychedelic experiences. This episode provides a comprehensive overview of the current state of psychedelic research, the challenges and opportunities in the field, and the potential for these substances to revolutionize mental health treatment. Join Dr. Dave Rabin and Dr. Jeff Chen as they navigate the complex and fascinating world of psychedelic medicines and healing.Web: https://radiclescience.com/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com

In this episode, Joe interviews Dr. Robin Carhart-Harris: founder and head of the Centre for Psychedelic Research at Imperial College London, founding director of the Neuroscape Psychedelics Division at University of California, San Francisco (UCSF), and founder of the Carhart-Harris Lab. A legendary researcher, he talks about his psychedelic origins: studying Freud, Jung, and eventually Stan Grof and depth psychology to try and better understand the unconscious. He discusses the growth of psychedelics and the cultural shifts he's noticed (especially in the U.S.), as well as what he's working on today: researching the influence of psychedelics on set and setting by studying experiences in both enriched and unenriched environments. He also talks about: Plasticity: how he defines it, how it relates to critical reopening periods, and how it's a fundamental thing that transcends the metrics we use to measure it Early LSD studies, the nervousness surrounding he and David Nutt dosing Ben Sessa, and the youthful energy that kept them going How plasticity could be exploited to help relieve chronic pain The potential of psychedelics to help with fibromyalgia and anorexia How psychedelic-assisted therapy brought care back to health care and more! UCSF is seeking survey volunteers, so if you've had more than three experiences with ketamine, MDMA, and psilocybin (must have experiences with all three) and want to contribute, do so here. Click here to head to the show notes page. 

In this week's episode of Life of Flow, embark on a deep exploration of psychedelic therapy Dr. Lucas Ferrer and Dr. Miguel Montero-Baker engage in an educational conversation with Dr. Charles Nemeroff, the co-director of the Center for Psychedelic Research and Therapy at Dell Medical. Dr. Nemeroff, shares profound insights into the therapeutic potential and intricacies of psychedelic treatments. From recounting transformative patient experiences to dissecting the underlying mechanisms of psychedelic-assisted therapy, Dr. Nemeroff provides a comprehensive overview of this groundbreaking approach to mental health. Delve into the nuances of psychedelic-induced consciousness exploration, as Dr. Nemeroff navigates through the delicate balance between therapeutic breakthroughs and potential risks. The conversation dives into ethical considerations surrounding accessibility, regulation, and responsible usage of psychedelics in clinical settings. As we peer into the future of mental healthcare, join us in unraveling the promise and challenges of integrating psychedelic therapy into mainstream treatment modalities. The Center for Psychedelic Research and Therapy at Dell Medical is currently recruiting for clinical trials. Learn more about the program and research here. This Episode is brought to you by Hope Vascular and Podiatry Follow Life of Flow on Twitter Follow Miguel Montero-Baker on Twitter

Episode #299. Could psychedelics be the answer to the mental health crisis? Join me as I sit down with psychologist and academic, Dr Stephen Bright, to examine the prevalence of drug usage, what this means in the context of mental health, and how psilocybin and MDMA might be the future of mental health treatment. You'll learn about the most common drugs in Australia, including cannabis, cocaine, MDMA, and psychedelics. We discuss how these drugs are portrayed in the media, why workplace drug screening may be harmful, and current and upcoming research in the field of psychedelics as a medical treatment option. Dr Bright also shares his views on how decriminalisation and legalisation can help protect vulnerable people. Specifically, we discuss: Introduction to the Podcast (0:00:00) Stephen Bright: Journey into Psychedelic Research (0:01:24) Trends in Drug Use Across Australia and Western Nations (0:06:52) Detecting Cocaine and Cannabis: Health Impacts (0:15:56) Legal Status of Synthetic Cannabis (0:18:35) Cannabis Usage Trends: Analysis (0:20:45) Vaping vs Smoking: Health Perspectives (0:28:10) Impact of Drug Use on Mental Health in Australia (0:31:26) Current Mental Health Treatment Approaches (0:37:07) Exploring Entheogens and Psychedelics (0:47:35) Academic Advancements in Psychedelic Research (0:49:58) Efficacy of MDMA and Psilocybin in Therapy (0:57:40) Psychedelic Research: Australia's Journey (1:11:02) Understanding Psychedelic Scepticism (1:17:17) Intersection of Psychedelics and Religious Practices (1:23:22) Psychedelics and Spiritual Awakening (1:27:12) Current Psychedelic Research Trends in Australia (1:29:34) Evolving Treatments for Mental Health Conditions (1:33:00) How Legalising Psychedelics Could Influence Drug Use (1:36:32) Psychedelics in Preventative Mental Health Strategies (1:38:35) Decriminalisation vs Legalisation of Psychedelics: A Comparative Analysis (1:41:28) Wrap-Up: Key Insights and Conclusions (1:56:40) Connect with Stephen Bright, PhD on LinkedIn and Twitter/X. Discover more of his work on Prism, Psychedelic Institute Australia (for healthcare practitioners), Students for Sensible Drug Policy, and AOD Media Watch. Sponsors: If you want to improve your health, you need to measure where you're currently at. InsideTracker analyses up to 48 blood biomarkers including ApoB, LDL, HDL, A1C, and more before giving you advice to optimise your health. Get a 20% discount on your first order at insidetracker.com/simon. Eimele Essential 8 is a comprehensive multivitamin that is scientifically formulated to complement your plant-rich diet, increase and sustain your energy, support the immune system, as well as heart and brain health. Head to Eimele.com and use code SIMON at checkout for 10% off your first order. People all over the world are using Reveri to quit smoking, gain control over other addictions, reduce physical pain, feel more relaxed, and improve their mental health. The Proof community members can use Reveri for 30 days free with a guest pass. Just visit reveri.com/theproof to redeem. Want to support the show? The best way to support the show is to use the products and services offered by our sponsors. To check them out, and enjoy great savings, visit theproof.com/friends. You can also show your support by leaving a review on the Apple Podcast app and/or sharing your favourite episodes with your friends and family. Simon Hill, MSc, BSc (Hons) Creator of theproof.com and host of The Proof with Simon Hill Author of The Proof is in the Plants Watch the episodes on YouTube or listen on Apple/Spotify Connect with me on Instagram, Twitter, and Facebook Nourish your gut with my Plant-Based Ferments Guide Download my complimentary Two-Week Meal Plan and high protein Plant Performance recipe book

Do psychedelics reveal a different objective reality? Neil deGrasse Tyson and Chuck Nice learn about psychedelic drugs, treating PTSD, and other mind-bending research with President of Multidisciplinary Association for Psychedelic Studies (MAPS) Rick Doblin.NOTE: StarTalk+ Patrons can listen to this entire episode commercial-free.Thanks to our Patrons Mark Rosenthal, David Aulwes, Alissa Mc Cormick, Gavin Bamber, Lester Teichner, Chase Kimes, and Cindy Barrick for supporting us this week.Photo Credit: Storyblocks

Dr. Peterson's extensive catalog is available now on DailyWire+: https://utm.io/ueSXhDr Jordan B Peterson and Dr. Robin Carhart-Harris delve into the world of psychedelic research, their utility in therapy, and the impact they can have on neuroticism. They also explore broader aspects of psychopathology, brain imaging, optimized play, and the way trauma can warp our perspectives of the world. Robin is the Ralph Metzner Distinguished Professor in Neurology and Psychiatry and Director of Neuroscape's Psychedelics Division at the University of California, San Francisco. He moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol. Robin has designed human brain imaging studies with LSD, psilocybin, MDMA and DMT, and several clinical trials of psilocybin therapy for severe mental illnesses. Robin founded the Centre for Psychedelic Research at Imperial College London in April 2019, was ranked among the top 31 medical scientists in 2020, and in 2021, was named in TIME magazine's ‘100 Next' – a list of 100 rising stars shaping the future. His research is creating system-level change in mental health care.  - Sponsors - Express VPN: Get 3 Months FREE of ExpressVPN: https://expressvpn.com/jordan Birch Gold: Text "JORDAN" to 989898 for a FREE Goldback with every $5000 purchase, when you convert an existing IRA or 401k into a precious metals IRA with Birch Gold by December 22nd. Black Rifle Coffee: Get 10% off your first order or Coffee Club subscription with code JORDAN: https://www.blackriflecoffee.com/ Exodus 90: Is it time for your Exodus? Find resources to prepare at https://exodus90.com/jordan.   - Links -  For Dr. Carhart-Harris: Twitter: https://twitter.com/RCarhartHarris Website:  https://neuroscape.ucsf.edu/profile/robin-carhart-harris/   - Chapters - (0:00) Coming Up(1:00) Intro(2:50) Implicit learning(7:52) Tuned perceptions, warped vantage points(12:00) Rebirth, rapid new learning(16:00) Alcoholism, unlearning pain(20:22) Neuroticism, Freud, and the disconnect(24:00) Cascading depression(30:10) Functional depression(35:30) The source of psychopathology(46:48) The psychedelic experience(49:47) Genetic mutation, error correction(53:30) Micro and macro environments(56:33) The multitude within(58:39) Pageau, optimized play(1:04:00) When play is absent from the system(1:07:25) Depth of play, levels of engagement(1:09:55) Local minima(1:13:29) Psychedelics and antidepressants(1:17:40) Creative surging under influence(1:21:30) Every benefit has a cost(1:23:32) Terrance and Dennis McKenna, false positives(1:26:15) Paranoid Schizophrenia(1:29:26) The feeling of confidence vs. uncertainty(1:33:33) Exposure therapy, building up bravery(1:35:00) Brain imaging, mapping experience(1:38:40) Entropic brain principle(1:40:00) Between order and chaos, Marduk(1:44:16) Signatures of criticality, the Alpha Rhythm       // SUPPORT THIS CHANNEL //Newsletter: https://mailchi.mp/jordanbpeterson.co...Donations: https://jordanbpeterson.com/donate // COURSES //Discovering Personality: https://jordanbpeterson.com/personalitySelf Authoring Suite: https://selfauthoring.comUnderstand Myself (personality test): https://understandmyself.com // BOOKS //Beyond Order: 12 More Rules for Life: https://jordanbpeterson.com/Beyond-Order12 Rules for Life: An Antidote to Chaos: https://jordanbpeterson.com/12-rules-...Maps of Meaning: The Architecture of Belief: https://jordanbpeterson.com/maps-of-m... // LINKS //Website: https://jordanbpeterson.comEvents: https://jordanbpeterson.com/eventsBlog: https://jordanbpeterson.com/blogPodcast: https://jordanbpeterson.com/podcast // SOCIAL //Twitter: https://twitter.com/jordanbpetersonInstagram: https://instagram.com/jordan.b.petersonFacebook: https://facebook.com/drjordanpetersonTelegram: https://t.me/DrJordanPetersonAll socials: https://linktr.ee/drjordanbpeterson #JordanPeterson #JordanBPeterson #DrJordanPeterson #DrJordanBPeterson #DailyWirePlus #podcast